Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · Real-Time Price · USD
2.510
+0.020 (0.80%)
At close: May 12, 2025, 4:00 PM
2.630
+0.120 (4.78%)
After-hours: May 12, 2025, 7:27 PM EDT
Telomir Pharmaceuticals Market Cap
Telomir Pharmaceuticals has a market cap or net worth of $74.70 million as of May 12, 2025. Its market cap has decreased by -63.80% in one year.
Market Cap
74.70M
Enterprise Value
73.53M
1-Year Change
-63.80%
Ranking
Category
Stock Price
$2.51
Market Cap Chart
Since the IPO on February 9, 2024, Telomir Pharmaceuticals's market cap has decreased from $207.27M to $74.70M, a decrease of -63.96%. That is a compound annual growth rate of -55.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 74.11M | -39.54% |
| Dec 31, 2024 | 122.58M | -40.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |